AI assistant
Sending…
RESMED INC — Director's Dealing 2018
Jan 4, 2018
30071_dirs_2018-01-04_03aff3cd-787b-4807-a4c2-0a53ad85cc85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-01-02
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-02 | ResMed Common Stock | S | 1250 | $84.99 | Disposed | 78322 | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 Plan.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29